172 related articles for article (PubMed ID: 31168295)
1. Establishment and characterization of a novel childhood acute lymphoblastic leukemia cell line, HXEX-ALL1, with chromosome 9p and 17p deletions.
Zhu Y; Yang R; Gao J; Zhang Y; Zhang G; Gu L
Cancer Cell Int; 2019; 19():113. PubMed ID: 31168295
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of HXWMF-1: the first mouse fibroblastic tumor cell line derived from leukemia-associated fibroblasts.
Li Y; Gu L
Cancer Cell Int; 2021 Mar; 21(1):177. PubMed ID: 33740980
[TBL] [Abstract][Full Text] [Related]
3. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract][Full Text] [Related]
4. The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome.
Caligiuri MA; Strout MP; Oberkircher AR; Yu F; de la Chapelle A; Bloomfield CD
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3899-902. PubMed ID: 9108076
[TBL] [Abstract][Full Text] [Related]
5. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.
Caligiuri MA; Strout MP; Schichman SA; Mrózek K; Arthur DC; Herzig GP; Baer MR; Schiffer CA; Heinonen K; Knuutila S; Nousiainen T; Ruutu T; Block AW; Schulman P; Pedersen-Bjergaard J; Croce CM; Bloomfield CD
Cancer Res; 1996 Mar; 56(6):1418-25. PubMed ID: 8640834
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.
Qiu H; Xue Y; Zhang J; Pan J; Dai H; Wu Y; Wang Y; Chen S; Wu D
Exp Hematol; 2008 Nov; 36(11):1487-95. PubMed ID: 18715689
[TBL] [Abstract][Full Text] [Related]
7. A new human acute monocytic leukemia cell line SHI-1 with t(6;11)(q27;q23), p53 gene alterations and high tumorigenicity in nude mice.
Chen S; Xue Y; Zhang X; Wu Y; Pan J; Wang Y; Ceng J
Haematologica; 2005 Jun; 90(6):766-75. PubMed ID: 15951289
[TBL] [Abstract][Full Text] [Related]
8. ALL1 gene alterations in acute leukemia: biological and clinical aspects.
Cimino G; Rapanotti MC; Sprovieri T; Elia L
Haematologica; 1998 Apr; 83(4):350-7. PubMed ID: 9592986
[TBL] [Abstract][Full Text] [Related]
9. Deletions and rearrangement of CDKN2 in lymphoid malignancy.
Stranks G; Height SE; Mitchell P; Jadayel D; Yuille MA; De Lord C; Clutterbuck RD; Treleaven JG; Powles RL; Nacheva E
Blood; 1995 Feb; 85(4):893-901. PubMed ID: 7849311
[TBL] [Abstract][Full Text] [Related]
10. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.
Caligiuri MA; Strout MP; Lawrence D; Arthur DC; Baer MR; Yu F; Knuutila S; Mrózek K; Oberkircher AR; Marcucci G; de la Chapelle A; Elonen E; Block AW; Rao PN; Herzig GP; Powell BL; Ruutu T; Schiffer CA; Bloomfield CD
Cancer Res; 1998 Jan; 58(1):55-9. PubMed ID: 9426057
[TBL] [Abstract][Full Text] [Related]
11. Interstitial insertion of AF10 into the ALL1 gene in a case of infant acute lymphoblastic leukemia.
Angioni A; La Starza R; Mecucci C; Sprovieri T; Matteucci C; De Rossi G; Balloni P; Cimino G
Cancer Genet Cytogenet; 1998 Dec; 107(2):107-10. PubMed ID: 9844603
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and characterization of a human acute monocytic leukemic cell line, SHI-1, carrying t(6;11)(q27;23) and p53 gene alteration].
Chen SN; Xue YQ; Zhang XG; Wu YF; Pan JL; Wang Y; Cen JN
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):94-9. PubMed ID: 15921626
[TBL] [Abstract][Full Text] [Related]
13. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias.
Cimino G; Rapanotti MC; Biondi A; Elia L; Lo Coco F; Price C; Rossi V; Rivolta A; Canaani E; Croce CM; Mandelli F; Greaves M
Cancer Res; 1997 Jul; 57(14):2879-83. PubMed ID: 9230194
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel glucocorticoid-resistant human B-cell acute lymphoblastic leukemia cell line, with AMPK, mTOR and fatty acid synthesis pathway inhibition.
Li Y; Zuo C; Gu L
Cancer Cell Int; 2021 Nov; 21(1):623. PubMed ID: 34823530
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
16. Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia.
Elia L; Gottardi E; Floriddia G; Grillo R; Ciambelli F; Luciani M; Chiusolo P; Invernizzi R; Meloni G; Foà R; Saglio G; Cimino G
Leukemia; 2004 Nov; 18(11):1824-30. PubMed ID: 15318246
[TBL] [Abstract][Full Text] [Related]
17. Molecular Cytogenetic Characterization of a Complex Karyotype of a Pediatric Male Patient with B-Acute Lymphoblastic Leukemia.
Nguyen AM; Tse V; Lapp K; Yang G; Cunnien K; Serk D; Tirado CA
J Assoc Genet Technol; 2020; 46(1):24-31. PubMed ID: 32161187
[TBL] [Abstract][Full Text] [Related]
18. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood.
Bertaina A; Vinti L; Strocchio L; Gaspari S; Caruso R; Algeri M; Coletti V; Gurnari C; Romano M; Cefalo MG; Girardi K; Trevisan V; Bertaina V; Merli P; Locatelli F
Br J Haematol; 2017 Feb; 176(4):629-636. PubMed ID: 28116786
[TBL] [Abstract][Full Text] [Related]
19. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
[TBL] [Abstract][Full Text] [Related]
20. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia.
Okuda T; Shurtleff SA; Valentine MB; Raimondi SC; Head DR; Behm F; Curcio-Brint AM; Liu Q; Pui CH; Sherr CJ
Blood; 1995 May; 85(9):2321-30. PubMed ID: 7727766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
